These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Rationale for investigation of epidermal growth factor receptor inhibitors in definitive treatment of locally advanced non-small cell lung cancer and head and neck cancer. Choy H; Kim DW Semin Respir Crit Care Med; 2004; 25 Suppl 1():33-43. PubMed ID: 16088519 [TBL] [Abstract][Full Text] [Related]
47. Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors. Krause M; Gurtner K; Deuse Y; Baumann M Int J Radiat Biol; 2009 Nov; 85(11):943-54. PubMed ID: 19895271 [TBL] [Abstract][Full Text] [Related]
48. Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis? Wierzbicka E; Tourani JM; Guillet G Br J Dermatol; 2006 Jul; 155(1):213-4. PubMed ID: 16792781 [No Abstract] [Full Text] [Related]